Trial intelligence / Profile preview

Dexmedetomidine and Sufentanil PCIA in Pediatric Scoliosis

NCT05249153Active, not recruiting

Sponsor
Peking Union Medical College Hospital
Start
Sep 2020
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of dexmedetomidine in postoperative pain (3 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Postoperative opioid analgesic dosage. Started Sep 2020; status: active, not recruiting.

02

Drugs

dexmedetomidine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05249153.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05249153.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call